Baxter International Inc.BAXNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -12.20% |
| 2024 | 13.90% |
| 2023 | 15.11% |
| 2022 | -15.25% |
| 2021 | 1.92% |
| 2020 | -12.44% |
| 2019 | -9.02% |
| 2018 | 6.34% |
| 2017 | -4.80% |
| 2016 | 7.13% |